Role and Value of Inflammatory Markers in Brain Tumors : A Case Controlled Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- Value of Procalcitonin
研究概览
简要总结
This study is a case controlled analytical study that analyzes the relationship between levels of inflammatory markers with the type of brain tumor. Samples of 35 people were then categorized according to the variables above and analyzing to measure its significance
详细描述
This study is a case controlled analytical study to find the relationship between levels of inflammatory markers in patients with brain tumors. Samples were collected from patients at Haji Adam Malik Hospital in Medan, then the patient's blood serum was taken to be checked for these variables. Sample collection began in March - September 2020. The sample obtained was 35 people who met the inclusion and exclusion criteria.
Inclusion criteria:
- Willing to be a sample
- Complete medical records
- Head scan and head contrast MRI have been performed to confirm the patient's diagnosis with a brain tumor
Exclusion criteria:
- The patient's age is over 70 years
- Patients with high comorbidities such as kidney failure, heart disease, diabetes, and others
- Patients with a history of brain tumor surgery or previous brain tumor treatment
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Willing to be a sample
- •Complete medical records
- •Head scan and head contrast MRI have been performed to confirm the patient's diagnosis with a brain tumor
排除标准
- •The patient's age is over 70 years
- •Patients with high comorbidities such as kidney failure, heart disease, diabetes, and others
- •Patients with a history of brain tumor surgery or previous brain tumor treatment
结局指标
主要结局
Value of Procalcitonin
时间窗: February-April 2020
Value of Procalcitonin in each group (Meningioma Group, Glioma Group and Brain metastasis group)
Value of C-Reactive Protein
时间窗: April- June 2020
Value of C-Reactive Protein in each group (Meningioma Group, Glioma Group and Brain metastasis group)
Value of Neutrophyl to Lymphocyte Ratio (NLR)
时间窗: June- August 2020
Value of NLR in each group (Meningioma Group, Glioma Group and Brain metastasis group)
次要结局
- Demographic of samples(August- October 2020)
研究者
Ridha Dharmajaya
Prof. Dr.
Universitas Sumatera Utara